MHLA
Maiden Holdings, Ltd. 6.625 NT 2046
Insurance - Property & Casualty
Market Cap$1.24B
5Y Perf.-43.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MHLA vs PRE
Revenue, margins, valuation, and 5-year total return — side by side.
PRE
Prenetics Global Limited
Medical - Diagnostics & Research
Market Cap$242M
5Y Perf.-85.9%
MHLA vs PRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MHLA | PRE |
|---|---|---|
| Industry | Insurance - Property & Casualty | Medical - Diagnostics & Research |
| Market Cap | $1.24B | $242M |
| Revenue (TTM) | $42M | $69M |
| Net Income (TTM) | $-211M | $-47M |
| Gross Margin | 100.0% | 47.2% |
| Operating Margin | 8.5% | -62.9% |
| Total Debt | $255M | $2M |
| Cash & Equiv. | $35M | $32M |
MHLA vs PRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MHLA
PRE
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Maiden Holdings, Lt… (MHLA) | 100 | 56.8 | -43.2% |
| Prenetics Global Li… (PRE) | 100 | 14.1 | -85.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MHLA vs PRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PRE leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Maiden Holdings, Ltd. 6.625 NT 2046 is the stronger pick specifically for operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MHLA
Maiden Holdings, Ltd. 6.625 NT 2046
The Insurance Pick
MHLA is the clearest fit if your priority is long-term compounding.
- 14.6% 10Y total return vs PRE's -86.1%
- -17.1% ROA vs PRE's -23.7%, ROIC 4.3% vs -20.8%
Best for: long-term compounding
PRE
Prenetics Global Limited
The Growth Play
PRE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 201.7%, EPS growth -14.0%, 3Y rev CAGR 91.5%
- Lower volatility, beta 0.27, Low D/E 1.3%, current ratio 3.01x
- 201.7% revenue growth vs MHLA's -36.8%
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PRE | 201.7% revenue growth vs MHLA's -36.8% |
| Quality / Margins | PRE | -67.4% margin vs MHLA's -5.1% |
| Stability / Safety | PRE | Lower D/E ratio (1.3% vs 5.6%) |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | PRE | +205.2% vs MHLA's -3.8% |
| Efficiency (ROA) | MHLA | -17.1% ROA vs PRE's -23.7%, ROIC 4.3% vs -20.8% |
MHLA vs PRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2018
Segment breakdown not available.
MHLA vs PRE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPRELAGGINGMHLA
MHLAMaiden Holdings, Ltd.…
2leads
PREPrenetics Global Limi…
3leads
6 Total Categories
CATEGORYLEADERvs MHLAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
PRE4/6
Valuation MetricsMultiples, price ratios, and targets
PRE2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MHLA5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PRE4/6
Risk & VolatilityBeta, volatility, and downside exposure
MHLA2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
PRE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRE is the larger business by revenue, generating $69M annually — 1.7x MHLA's $42M. Profitability is closely matched — net margins range from -67.4% (PRE) to -5.1% (MHLA). On growth, PRE holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| RevenueTrailing 12 months | $42M | $69M |
| EBITDAEarnings before interest/tax | -$4M | -$54M |
| Net IncomeAfter-tax profit | -$211M | -$47M |
| Free Cash FlowCash after capex | -$97M | $0 |
| Gross MarginGross profit ÷ Revenue | +100.0% | +47.2% |
| Operating MarginEBIT ÷ Revenue | +8.5% | -62.9% |
| Net MarginNet income ÷ Revenue | -5.1% | -67.4% |
| FCF MarginFCF ÷ Revenue | -2.3% | -23.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -51.4% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.3% | +36.9% |
PRE leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
PRE leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| Market CapShares × price | $1.2B | $242M |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $212M |
| Trailing P/EPrice ÷ TTM EPS | -6.21x | -3.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 69.43x | — |
| Price / SalesMarket cap ÷ Revenue | 22.04x | 2.62x |
| Price / BookPrice ÷ Book value/share | 27.59x | 1.28x |
| Price / FCFMarket cap ÷ FCF | — | — |
PRE leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
MHLA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PRE delivers a -28.9% return on equity — every $100 of shareholder capital generates $-29 in annual profit, vs $-6 for MHLA. PRE carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MHLA's 5.64x. On the Piotroski fundamental quality scale (0–9), PRE scores 5/9 vs MHLA's 2/9, reflecting solid financial health.
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| ROE (TTM)Return on equity | -5.6% | -28.9% |
| ROA (TTM)Return on assets | -17.1% | -23.7% |
| ROICReturn on invested capital | +4.3% | -20.8% |
| ROCEReturn on capital employed | +1.5% | -21.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 |
| Debt / EquityFinancial leverage | 5.64x | 0.01x |
| Net DebtTotal debt minus cash | -$35M | -$30M |
| Cash & Equiv.Liquid assets | $35M | $32M |
| Total DebtShort + long-term debt | $255M | $2M |
| Interest CoverageEBIT ÷ Interest expense | -11.74x | -199.93x |
MHLA leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MHLA five years ago would be worth $9,450 today (with dividends reinvested), compared to $1,393 for PRE. Over the past 12 months, PRE leads with a +205.2% total return vs MHLA's -3.8%. The 3-year compound annual growth rate (CAGR) favors PRE at 7.6% vs MHLA's 6.7% — a key indicator of consistent wealth creation.
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| YTD ReturnYear-to-date | -0.8% | +0.6% |
| 1-Year ReturnPast 12 months | -3.8% | +205.2% |
| 3-Year ReturnCumulative with dividends | +21.6% | +24.5% |
| 5-Year ReturnCumulative with dividends | -5.5% | -86.1% |
| 10-Year ReturnCumulative with dividends | +14.6% | -86.1% |
| CAGR (3Y)Annualised 3-year return | +6.7% | +7.6% |
PRE leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
MHLA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MHLA is the less volatile stock with a -0.05 beta — it tends to amplify market swings less than PRE's 0.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MHLA currently trades 79.5% from its 52-week high vs PRE's 67.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.05x | 0.27x |
| 52-Week HighHighest price in past year | $15.70 | $23.63 |
| 52-Week LowLowest price in past year | $9.93 | $5.07 |
| % of 52W HighCurrent price vs 52-week peak | +79.5% | +67.2% |
| RSI (14)Momentum oscillator 0–100 | 60.3 | 37.1 |
| Avg Volume (50D)Average daily shares traded | 3K | 186K |
MHLA leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | MHLAMaiden Holdings, … | PREPrenetics Global … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $36.00 |
| # AnalystsCovering analysts | — | 1 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
PRE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MHLA leads in 2 (Profitability & Efficiency, Risk & Volatility).
Best OverallPrenetics Global Limited (PRE)Leads 3 of 6 categories
Loading custom metrics...
MHLA vs PRE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MHLA or PRE a better buy right now?
For growth investors, Prenetics Global Limited (PRE) is the stronger pick with 201.
7% revenue growth year-over-year, versus -36. 8% for Maiden Holdings, Ltd. 6. 625 NT 2046 (MHLA). Analysts rate Prenetics Global Limited (PRE) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MHLA or PRE?
Over the past 5 years, Maiden Holdings, Ltd.
6. 625 NT 2046 (MHLA) delivered a total return of -5. 5%, compared to -86. 1% for Prenetics Global Limited (PRE). Over 10 years, the gap is even starker: MHLA returned +14. 6% versus PRE's -86. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MHLA or PRE?
By beta (market sensitivity over 5 years), Maiden Holdings, Ltd.
6. 625 NT 2046 (MHLA) is the lower-risk stock at -0. 05β versus Prenetics Global Limited's 0. 27β — meaning PRE is approximately -685% more volatile than MHLA relative to the S&P 500. On balance sheet safety, Prenetics Global Limited (PRE) carries a lower debt/equity ratio of 1% versus 6% for Maiden Holdings, Ltd. 6. 625 NT 2046 — giving it more financial flexibility in a downturn.
04Which is growing faster — MHLA or PRE?
By revenue growth (latest reported year), Prenetics Global Limited (PRE) is pulling ahead at 201.
7% versus -36. 8% for Maiden Holdings, Ltd. 6. 625 NT 2046 (MHLA). On earnings-per-share growth, the picture is similar: Prenetics Global Limited grew EPS -14. 0% year-over-year, compared to -428. 9% for Maiden Holdings, Ltd. 6. 625 NT 2046. Over a 3-year CAGR, PRE leads at 91. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MHLA or PRE?
Prenetics Global Limited (PRE) is the more profitable company, earning -63.
1% net margin versus -356. 1% for Maiden Holdings, Ltd. 6. 625 NT 2046 — meaning it keeps -63. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MHLA leads at 37. 4% versus -40. 5% for PRE. At the gross margin level — before operating expenses — MHLA leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MHLA or PRE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MHLA or PRE better for a retirement portfolio?
For long-horizon retirement investors, Maiden Holdings, Ltd.
6. 625 NT 2046 (MHLA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 05)). Both have compounded well over 10 years (MHLA: +14. 6%, PRE: -86. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MHLA and PRE?
These companies operate in different sectors (MHLA (Financial Services) and PRE (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MHLA is a small-cap quality compounder stock; PRE is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(MHLA: -51.4% · PRE: 202.8%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.